Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol in Alzheimer's Disease
NCT02500784Phase 2Withdrawn
- Sponsor
- Palo Alto Veterans Institute for Research
- Start
- Jan 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of formoterol in Alzheimer's disease (AD), sponsored by Palo Alto Veterans Institute for Research. Planned start Jan 2023; status: withdrawn.
02
Drugs
formoterol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02500784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02500784.